FindMyKOL
Clinical trialNCT02807675CompletedPhase 1Interventional

A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)

SponsorAcorda TherapeuticsEnrollment36Parkinson's Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a double-blind, randomized, placebo-controlled, 2-way crossover study to evaluate the safety of CVT-301 levodopa (l-dopa) when co- administered with the first daily dose of oral levodopa/carbidopa for early morning OFF symptoms in patients with Parkinson's disease (PD).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Site #9015

    Fountain Valley, California, United States

  • Site #9002

    Boca Raton, Florida, United States

  • Site #9017

    Hallandale, Florida, United States

  • Site #9008

    St. Petersburg, Florida, United States

  • Site #9018

    Sunrise, Florida, United States

  • Site #9004

    Tampa, Florida, United States

  • Site #9016

    Atlanta, Georgia, United States

  • Site #9009

    Chicago, Illinois, United States

  • Site #9003

    Farmington Hills, Michigan, United States

  • Site #9005

    West Bloomfield, Michigan, United States

  • Site #9007

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CVT-301, LIP
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2016
Primary completion
30 Nov 2016
Completion
30 Nov 2016
Last update posted
30 Jan 2017
Registered enrollment
36
Registry id
NCT02807675
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.